a product of Scientific American Custom Media


  •  Johnson & Johnson

    Learn how Johnson & Johnson Innovation is helping entrepreneurs and scientists develop important medical device and diagnostic technologies, consumer healthcare products, and pharmaceuticals at

  •  Celgene
  •  Defining "Value" In Cancer Care
  •  Progress Through Politics

    There is a grave disconnect between medical science and government policy. On a national level, closing that gap certainly seems to be a bridge too far, but on a state level, we are making connections – bi-partisan connections - to achieve what we call the right treatment, for the right patient, right now.

  •  Covance
  •  Melbourne is Australia's Biotechology Capital

    A strong focus on global biotechnology opportunities is helping Melbourne cement its position as Australia's leading location for medical technologies and pharmaceuticals. Its success can be attributed to a combination of its educated population, strong academic institutions, favourable regulatory and R&D environment, and a supportive government.

  •  GSK
  •  Merck KGaA, Darmstadt, Germany

    There are legacies. And then there are LEGACIES.

  • A Guided Tour

    Enhanced with a new guidebook and region-specific ratings, the 2016 Scorecard ventures deeper than ever to track down the latest in biotech innovation